We are live on ! Find out more
CLB icon

Core Laboratories

176 hedge funds and large institutions have $905M invested in Core Laboratories in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 58 increasing their positions, 66 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more call options, than puts

Call options by funds: $2M | Put options by funds: $899K

1.53% more ownership

Funds ownership: 97.11%98.64% (+1.5%)

10% less funds holding

Funds holding: 196176 (-20)

12% less repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 66

36% less capital invested

Capital invested by funds: $1.42B → $905M (-$515M)

40% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 35

Holders
176
Holders Change
-20
Holders Change %
-10.2%
% of All Funds
2.96%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
21
Increased
58
Reduced
66
Closed
35
Calls
$2M
Puts
$899K
Net Calls
+$1.1M
Net Calls Change
-$9.59M

CLB Hedge Fund Activity: Q2 2022 in Review

176 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q2 2022, worth a combined $905M — down 36% from $1.42B a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of CLB and 21 opened new positions — a net loss of 14 holders — while 66 trimmed existing stakes and 58 added.

The largest buyer was Boston Trust Walden, opening a new position worth an estimated $53M. The largest seller was C Partners Holding, exiting entirely with an estimated $23.2M sold.

  • 176 institutional investors held Core Laboratories (CLB) as of Q2 2022, down from 196 in Q1 2022.
  • Funds reported $905M of Core Laboratories stock for Q2 2022, down 36% quarter-over-quarter.
  • 21 funds opened new Core Laboratories positions in Q2 2022 and 35 closed out, a net change of -14 holders.
  • The largest Core Laboratories buyer in Q2 2022 was Boston Trust Walden, an estimated $53M added.
  • The largest Core Laboratories seller in Q2 2022 was C Partners Holding, an estimated $23.2M sold.

Based on aggregated 13F filings for Q2 2022.